首页> 外文期刊>American journal of medical genetics, Part A >Barriers for integrating personalized medicine into clinical practice: A qualitative analysis
【24h】

Barriers for integrating personalized medicine into clinical practice: A qualitative analysis

机译:将个性化医学纳入临床实践的障碍:定性分析

获取原文
获取原文并翻译 | 示例
           

摘要

Personalized medicine-tailoring interventions based on individual's genetic information-will likely change routine clinical practice in the future. Yet, how practitioners plan to apply genetic information to inform medical decision making remains unclear. We aimed to investigate physician's perception about the future role of personalized medicine, and to identify the factors that influence their decision in using genetic testing in their practice. We conducted three semi-structured focus groups in three health regions (Fraser, Vancouver coastal, and Interior) in British Columbia, Canada. In the focus groups, participants discussed four topics on personalized medicine: (i) physicians' general understanding, (ii) advantages and disadvantages, (iii) potential impact and role in future clinical practice, and (iv) perceived barriers to integrating personalized medicine into clinical practice. Approximately 36% (n=9) of physicians self-reported that they were not familiar with the concept of personalized medicine. After introducing the concept, the majority of physicians (68%, n=19 of 28) were interested in incorporating personalized medicine in their practice, provided they have access to the necessary knowledge and tools. Participants mostly believed that genetic developments will directly affect their practice in the future. The key concerns highlighted were physician's access to clinical guidelines and training opportunities for the use of genetic testing and data interpretation. Despite the challenges that personalized medicine can create, in general, physicians in the focus groups expressed strong interest in using genetic information in their practice if they have access to the necessary knowledge and tools.
机译:基于个人遗传信息的个性化药物定制干预措施将来可能会改变常规临床实践。然而,从业者如何计划应用遗传信息来指导医疗决策仍不清楚。我们旨在调查医生对个性化医学未来作用的看法,并确定影响他们在实践中使用基因检测的决定的因素。我们在加拿大不列颠哥伦比亚省的三个健康区域(弗雷泽,温哥华沿海和内陆地区)进行了三个半结构性焦点小组讨论。在焦点小组中,参与者讨论了有关个性化医学的四个主题:(i)医师的一般理解,(ii)优缺点,(iii)在未来临床实践中的潜在影响和作用,以及(iv)集成个性化医学的感知障碍进入临床实践。大约36%(n = 9)的医生自我报告说,他们不熟悉个性化医学的概念。引入该概念后,大多数医生(68%,n = 28,共28位)对将个性化医学纳入其实践很感兴趣,只要他们能够获得必要的知识和工具即可。与会者大多认为,遗传发展将直接影响其未来的实践。重点关注的重点是医师获得临床指南的机会以及使用基因检测和数据解释的培训机会。尽管个性化医学可能会带来挑战,但总体而言,焦点小组的医生表示,如果他们能够获得必要的知识和工具,则对在实践中使用遗传信息表示出浓厚的兴趣。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号